Warning letter
Yusef Manufacturing Laboratories, LLC: warning letter of May 25, 2017
FDA warning letter 506591 · Los Angeles District Office
Key facts
| Reference number | 506591 |
|---|---|
| Company | Yusef Manufacturing Laboratories, LLC |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | May 25, 2017 |
| Posted date | Jun 6, 2017 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.34, 211.192, 211.22(d), 211.165(a), 211.100(a), 211.84(d)(1) |
| Inspection city | Clearfield |
| Inspection ZIP | 84016 |
| Inspection start date | May 23, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: